Previous 10 | Next 10 |
Gainers: LSB Industries (NYSE:LXU) +13%. Gran Tierra Energy (NYSE:GTE) +12%. New Pacific Metals (NYSE:NEWP) +11%. Kosmos Energy (NYSE:KOS) +11%. Precision Drilling (NYSE:PDS) +10%. Losers: Mesabi Trust (NYSE:MSB) -28%. The Chemours (NYSE:CC) -15%. Fluence Energy (NASDAQ:FLNC) -11%. ...
Shares of Chemours (NYSE: CC) , a specialty chemical company, fell sharply at the open of trading on Friday, losing as much as 14.5% of their value in the first few minutes of trading. The big story was the company's earnings release, which hit the market after the close on Thursday...
The following slide deck was published by The Chemours Company in conjunction with their 2021 Q4 earnings call. For further details see: The Chemours Company 2021 Q4 - Results - Earnings Call Presentation
Chemours (CC -12.6%) plunges to a two-month low after missing Q4 adjusted earnings estimates and issuing disappointing guidance for FY 2022 earnings. Q4 net income surged to $233M from $19M in the year-earlier quarter, while adjusted EBITDA rose 25% Y/Y to $307M; for the full year, net income...
--News Direct-- Name: Stefanie Kopchick Title: Global Market Manager, Opteon Stationary Refrigerants Age: 38 Educational Experience: Bachelor's Degree in Chemical Engineering with a Minor in Materials Science, Princeton University Professional Credentials/Accreditation...
ProQR Therapeutics (NASDAQ:PRQR) -69% after the trial for sepofarsen in Leber congenital amaurosis did not meet main goal. Betterware de Mexico (NASDAQ:BWMX) -26% on Q4 earnings release. Hudson Capital (NASDAQ:HUSN) -13%. PetVivo Holdings (NASDAQ:PETV) -18% on...
Chemours press release (NYSE:CC): Q4 Non-GAAP EPS of $0.81 misses by $0.07. Revenue of $1.6B (+19.4% Y/Y) beats by $30M. For FY2022, the company expects Adjusted EBITDA between $1.3B and $1.425B, up 8% Y/Y; Adjusted EPS between ~$4.07 and $4.70 vs. consensus of $4.50.; Free Cash Flow ...
Broad strength despite logistics and pandemic related headwinds – full year 2022 outlook targets continued earnings growth and strong free cash flow generation The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market p...
Chemours (NYSE:CC) is scheduled to announce Q4 earnings results on Thursday, Feb. 10, after market close. The consensus EPS estimate is $0.88 (+44.3% Y/Y) and the consensus revenue estimate is $1.57B (+17.2% Y/Y). Over the last 2 years, CC has beaten EPS estimates 100% of the time and has bea...
The Chemours Company (NYSE:CC) declares $0.25/share quarterly dividend, in line with previous. Forward yield 2.77% Payable March 15; for shareholders of record Feb. 25; ex-div Feb. 24. For further details see: The Chemours Company declares $0.25 dividend
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 16, 2024 / The Chemours Company Earlier this year, Chemours released our annual Sustainability Report titled, "Partnering for Progress." Throughout the report, we showcase how Chemours embraces partnerships to deliver innovative products responsibly and mor...
NORTHAMPTON, MA / ACCESSWIRE / July 12, 2024 / At Chemours, we believe that by exposing future generations to the wonders of chemistry, we can change even more lives for the better. To achieve this mission, we continue to invest and engage in science, technology, engineering, and math (STEM) edu...
The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company expects to issue its second quarter 2024 financial results after market close on Thursday, August 1, 2024. The Company expects to hold its conference call to discuss its ...